Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human TNF-alpha Protein, (active trimer) (MALS verified), His Tag, 100 µg  

Recombinant Human TNF-alpha Protein, (active trimer) (MALS verified), His Tag, 100 µg

Recombinant Human TNF-alpha Protein, (active trimer) (MALS verified), AA Val 77 - Leu 233, expressed in human 293 cells (HEK293), His Tag

Synonym: Recombinant huma protein, DIF,TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα

More details

TNA-H5228-100

Availability: within 7 days

403,00 €

Background
Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.

Source
Recombinant Human TNF-alpha, His Tag (active trimer) (MALS verified) (TNA-H5228) is expressed from human 293 cells (HEK293). It contains AA Val 77 - Leu 233 (Accession # NP_000585.2).
Predicted N-terminus: Val 77

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 18.3 kDa. The protein migrates as 17-19 kDa under reducing (R) condition (SDS-PAGE).

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Trehalose is added as protectant before lyophilization.

Reconstitution
See Certificate of Analysis for reconstitution instructions and specific concentrations.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity"
Silva, Gonçalves, Oliveira et al
Vaccines (Basel) (2023) 11 (8)
(2) "An Insight on the Possible Association between Inflammatory Bowel Disease and Biologic Therapy with IL-17 Inhibitors in Psoriasis Patients"
Orzan, Țieranu, Olteanu et al
Pharmaceutics (2023) 15 (8)
(3) "Cardiomyocyte-Targeting Peptide to Deliver Amiodarone"
Zahid, Weber, Yurko et al
Pharmaceutics (2023) 15 (8)
Showing 1-3 of 258349 papers.

The following products could also be interesting for you: